¹Saroj Kumar Debnath , ²Laxmidhar Barik  , ³Dipsundar Sahu , ⁴Jayram Hazra 

DOI : http://dx.doi.org/10.31142/ijahm/v10i1.06

 ¹Research Officer (Ayurveda), Central Ayurveda Research Institute for Drug Development, Kolkata, West Bengal, India, Central Council for Research in Ayurvedic Sciences,  Ministry of AYUSH, Government of India.

²Research Officer (Ayurveda), Central Ayurveda Research Institute for Drug Development, Kolkata, West Bengal, India, Central Council for Research in Ayurvedic Sciences,  Ministry of AYUSH, Government of India.

³Research Officer (Ayurveda), Central Ayurveda Research Institute for Drug Development, Kolkata, West Bengal, India, Central Council for Research in Ayurvedic Sciences,  Ministry of AYUSH, Government of India.

⁴Director, Central Ayurveda Research Institute for Drug Development, Kolkata, West Bengal, India, Central Council for Research in Ayurvedic Sciences,  Ministry of AYUSH, Government of India. 

* Correspondence Author:  Saroj Kumar Debnath,

B.Sc. (Bot. Hon.), B.A.M.S. (C.U.), M.D. (C.U.), Ph.D. (G.A.U.),

Research Officer (Ayurveda), Central Ayurveda Research Institute for Drug Development,

4 CN Block, Sector- V, Salt Lake City, Kolkata 700091, India.

 

Download Pdf 

Abstract:

45 Amavata (Rheumatoid arthritis) patients had been selected from the O.P.D. & I.P.D. of Central Ayurveda Research Institute for Drug Development, Kolkata for the clinical study. 40 patients were completed the treatment out of 45 and 5 patients were dropped out from the study before completion of the treatment. The objective of the study was to evaluate the safety and efficacy of selected Ayurvedic medicines on the management of Amavata (Rheumatoid arthritis) during study. The treatment schedule was that 250 mg Amavatari Ras (Ayurvedic pill medicine) orally thrice in a day after meal with warm water for 30 days & Brihat saindyabadi taila (Ayurvedic oil medicine) applied locally over affected joints twice in a day for 30 days. In present clinical study 35 % patients got major improvement, 50% patients got minor improvement, 10% patients showed no improvement and complete remission was nil. No adverse drug reaction was observed during the study.

Key Words: Amavata, Rheumatoid arthritis, Amavatari Ras, Brihat saindyabadi taila.

 

References:  

1.   Madhavakara, Shastri S., Upadhyaya Y. Madhava Nidana with Madhukokosha Vyakya and Vidyotini Hindi Commentry. 26th edition. Varanasi; Chaukhambha Sanskrit Sanathana; 1996.

2.      Harrison, T.R., Anthony S. Fauci et al. Harrison’s Principles of Internal Medicine. 14th edition. New York; Mc Graw-Hill; 1998.

3.      Govindadassen, Mishra S. N. Bhaishaijya Ratnavali with Siddhiprada Hindi Commentary. 1st edition. Varanasi; Chaukhambha Surabharati Prakashan; 2005.

4.      Govindadassen, Mishra S. N. Bhaishaijya Ratnavali with Siddhiprada Hindi Commentary. 1st edition. Varanasi; Chaukhambha Surabharati Prakashan; 2005.